abstract |
The present invention relates to novel methylenedioxyphenol compounds and their derivatives, methods for their production, and cardiovascular diseases, vascular diseases and / or inflammatory diseases, and type I and type II diabetes using them. And methods of treating or preventing patients with dyslipidemia associated with the risk of hypertension, stroke, cardiovascular disease and kidney disease. [Selection] Figure 1 |